Organization
Salix Pharmaceuticals, Inc.
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Salix Pharmaceuticals, Inc.
... Scientist of Glycyx PharmaVentures Ltd. He is also a founder of Salix Pharmaceuticals, Inc. and held senior leadership positions at Salix prior to its $15.8 ...
... -- Shareholder attempts to rescue a challenge to the $13.1 billion Salix Pharmaceuticals Inc. merger with Valeant Pharmaceuticals International Inc. in 2015 hit turbulence in ...
... clinical programs." Most recently, Mr. Creech served as Acting CFO of Salix Pharmaceutical, Inc., a publicly-held specialty pharmaceutical company acquired by Valeant for $11 billion ...
... International, Inc., a specialty pharmaceutical company, has announced that its subsidiary, Salix Pharmaceuticals, Inc., has received approval from the FDA for Xifaxan 550mg for the ...
... strategic licensing agreement with the North Carolina based GI specialty company Salix Pharmaceuticals Inc. The agreement grants Lupin exclusive rights to promote, distribute and market ...
... rival bid from Endo International by bumping up its offer for Salix Pharmaceuticals Inc. to $11.1 billion, or $173 per share. The new proposal, according ...
... Extended-release Tablets, 9 mg. Actavis' ANDA product is a generic version of Salix Pharmaceuticals' Uceris®, which is a glucocorticosteroid indicated for the induction of remission ...
... 15 per cent following news that the Montreal-based company would purchase Salix Pharmaceuticals Inc. of Raleigh, N.C., for $158 (U.S.) a share, or $10-billion, plus ...
... expected future cash flows of Glumetza in 2015. In late 2014, Salix Pharmaceuticals, Inc. (Salix) disclosed there was an excess of supply of Glumetza and ...
... States, where the product is available as UCERIS®, the licensee is Salix Pharmaceuticals, Inc. ### About CORTIMENT®MMX® CORTIMENT®MMX® contains budesonide, a locally acting glucocorticosteroid, in ...
... Endo said to be jousting with Valeant, Shire to win Salix With Valeant ($VRX) and Shire ($SHPG) already said to be prepping bids ...
... Check out which companies are making headlines before the bell : Salix Pharmaceuticals – Shire is working with advisers on a potential offer for ...
... Shire and Valeant are reportedly eyeing $10B bids for Salix Salix Pharmaceuticals ($SLXP), moving on from an embarrassing inventory scandal, is reportedly ...
... reportedly lined up financing to make a takeover run at Raleigh's Salix Pharmaceuticals (NASDAQ: SLXP), another is getting is said to be doing the same. ...
... Salix Pharmaceuticals, a maker of gastrointestinal drugs that played a role in last ...
... on the following equities: Valeant Pharmaceuticals International Inc. (NYSE: VRX), Salix Pharmaceuticals Ltd (NASDAQ: SLXP), The Medicines Company (NASDAQ: MDCO), Hospira Inc. (NYSE: HSP), and ...
... is casting a wider net, Bloomberg reports. That could include GI specialist Salix Pharmaceuticals ($SLXP), which Shire reportedly has its eye on. After all, GI ...
... UPDATED: Valeant, Shire prep Salix bids Valeant CEO J. Michael Pearson Earlier this month, rumors started swirling ...
... 2017. Valeant is reportedly in talks to decide whether to take over Salix Pharmaceuticals, Bloomberg reported Tuesday. According to unnamed sources, Valeant has begun discussions ...
... Raleigh's Salix Pharmaceuticals (NASDAQ: SLXP) is again in the eye of a larger pharma company. ...
... Raleigh's Salix to wage a second patent infringement fight Raleigh's Salix Pharmaceuticals (NASDAQ: ...
... being tried to verdict by a jury in the Napo vs. Salix Pharmaceuticals, Inc. ("Salix") litigation. Napo filed a lawsuit against Salix in New York ...
... Pharmaceuticals SpA informs that Santarus, Inc., a wholly owned subsidiary of Salix Pharmaceuticals, Ltd., and its subsidiary, Cosmo Technologies Limited ("Cosmo"), the licensor, commenced a ...
... Salix Announces the Promotion of William P. Forbes, PharmD to President, Medical, R&D ...
Want to see the full history of news or view news on a particular date? Upgrade to RelSci Professional now!
Start My Free Trial ➤